| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 408 |
| 1 | INFLIXIMAB | 69 |
| 2 | PREDNISONE | 62 |
| 3 | AZATHIOPRINE | 59 |
| 4 | BEVACIZUMAB | 56 |
| 5 | METHOTREXATE SODIUM | 49 |
| 6 | METHOTREXATE | 42 |
| 7 | VEDOLIZUMAB | 40 |
| 8 | ACETAMINOPHEN | 33 |
| 9 | PACLITAXEL | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 1 | NAPROXEN SODIUM 220 MG | 1 | 0.0063 |
| 2 | FLOXURIDINE | 1 | 0.0058 |
| 3 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0047 |
| 4 | ENALAPRILAT | 1 | 0.0039 |
| 5 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 6 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 7 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 8 | FROVATRIPTAN SUCCINATE | 2 | 0.0025 |
| 9 | IXABEPILONE | 2 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 23 | 0.0017 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 6 | 0.0009 |
| 2 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 3 | Purine Antimetabolite [EPC] | 60 | 0.0006 |
| 4 | Integrin Receptor Antagonist [EPC] | 40 | 0.0005 |
| 5 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 6 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 26 | 0.0004 |
| 8 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 57 | 0.0003 |